medigraphic.com
Instituto Nacional de Salud Pública

2019, Number 3

<< Back Next >>

salud publica mex 2019; 61 (3)

Incidence, mortality and associated costs of lung cancer in the Mexican Institute of Social Security

Rascón-Pacheco RA, González-León M, Arroyave-Loaiza MG, Borja-Aburto VH

Language: Spanish
References: 29
Page: 257-264
PDF size: 550.72 Kb.


ABSTRACT

Objective. To describe temporal trends in lung cancer incidence, mortality and associated health care costs in the Mexican Institute of Social Security. Materials and methods. Incident cases were estimated from hospital discharges in 276 IMSS hospitals between 2006 and 2016. Crude and adjusted mortality rates were calculated. The costs of outpatient and inpatient treatment were calculated based on the medical-technical costs of reference o standard cost. Results. Both incidence and mortality had a decreased time trend. The cost of medical care for the 2 539 patients in 2017 was 42 million US dollars, with an average cost per patient of 16 537 US dollars. The cost per annum of disability pensions is 97.2 million pesos. Conclusions. It is likely that the reduction of the risk of getting sick and dying from lung cancer in IMSS affiliates is due to the control measures of tobacco smoke. It is still necessary to establish strategies to diagnose and treat patients in early stages.


REFERENCES

  1. Organización Mundial de la Salud. Cáncer. Ginebra: OMS, 2018. [citado mayo 4, 2018]. Disponible en: http://www.who.int/es/news-room/factsheets/ detail/cancer

  2. Gomez-Dantes H, Lamadrid-Figueroa H, Cahuana-Hurtado L, Silverman- Retana O, Montero P, Gonzalez-Robledo MC, et al. The burden of cancer in Mexico, 1990-2013. Salud Publica Mex. 2016;58(2):118-31. https://doi. org/10.21149/spm.v58i2.7780

  3. Borja-Aburto VH, Davila-Torres J, Rascon-Pacheco RA, Gonzalez- Leon M, Fernandez-Garate JE, Mejia-Rodriguez I, et al. Cancer mortality in the Mexican Social Security Institute, 1989-2013. Salud Publica Mex. 2016;58(2):153-61. https://doi.org/10.21149/spm.v58i2.7784

  4. Hernandez-Garduno E, Ocana-Servin HL. Lung cancer mortality trends in Mexico, 1999-2014. Salud Publica Mex. 2018;60(3):366-9. https://doi. org/10.21149/8730

  5. Tovar-Guzman VJ, Lopez-Antunano FJ, Rodriguez-Salgado N. Trends in mortality from lung cancer in Mexico, 1980-2000. Rev Panam Salud Publica. 2005;17(4):254-62.

  6. Malvezzi M, Bosetti C, Chatenoud L, Rodriguez T, Levi F, Negri E, La Vecchia C. Trends in cancer mortality in Mexico, 1970-1999. Ann Oncol. 2004;15(11):1712-8. https://doi.org/10.1093/annonc/mdh424

  7. Rowell TR, Tarran R. Will chronic e-cigarette use cause lung disease? Am J Physiol Lung Cell Mol Physiol. 2015;309(12):L1398-409. https://doi. org/10.1152/ajplung.00272.2015

  8. Li Y, Shi J, Yu S, Wang L, Liu J, Ren J, et al. Health Economic Evaluation Working Group CSPiUC. Effect of socioeconomic status on stage at diagnosis of lung cancer in a hospital-based multicenter retrospective clinical epidemiological study in China, 2005-2014. Cancer Med. 2017;6(10):2440- 52. https://doi.org/10.1002/cam4.1170

  9. Frumkin H, Samet JM, Radon CA. Cancer J Clin. 2001;51(6):337-44, 322; quiz 345-338. https://doi.org/10.3322/canjclin.51.6.337

  10. Knaul FM, Gonzalez-Pier E, Gomez-Dantes O, Garcia-Junco D, Arreola- Ornelas H, Barraza-Llorens M, et al. The quest for universal health coverage: achieving social protection for all in Mexico. Lancet. 2012;380(9849):1259- 79. https://doi.org/10.1016/S0140-6736(12)61068-X

  11. Gildea TR, DaCosta-Byfield S, Hogarth DK, Wilson DS, Quinn CC. A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. Clinicoecon Outcomes Res. 2017;9:261-9. https://doi. org/10.2147/CEOR.S132259

  12. McGuire A, Martin M, Lenz C, Sollano JA. Treatment cost of nonsmall cell lung cancer in three European countries: comparisons across France, Germany, and England using administrative databases. J Med Econ. 2015;18(7):525-32. https://doi.org/10.3111/13696998.2015.1032974

  13. Instituto Nacional de Estadística y Geografía. Mortalidad. México: INEGI, 2018. [citado mayo 21, 2018]. Disponible en: https://www.inegi.org. mx/temas/mortalidad/default.html#Informacion_general

  14. Arroyave-Loaiza MG. Grupos relacionados con el diagnóstico: Producto Hospitalario, GRD-IMSS: 2014. Ciudad de México: IMSS, 2016.

  15. Arroyave-Loaiza MG, Amador-Vázquez L, Lara-Gómez JE, Rodríguez- Díaz Ponce MA, Dávila-Torres J. Grupos relacionados con la atención ambulatoria de las enfermedades endocrinas, nutricionales y metabólicas EGRAA. Ciudad de México: IMSS, 2014.

  16. Reynales-Shigematsu LM. Tobacco and cancer: epidemiology and new perspectives of prevention and monitoring in Mexico. Salud Publica Mex. 2016;58(2):251-60. https://doi.org/10.21149/spm.v58i2.7794

  17. American Cancer Society. Cancer Facts & Figures. USA: American Cancer Society, 2018. [citado agosto 22, 2018]. Disponible en: https://www. cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/ annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf

  18. Zhi XY, Zou XN, Hu M, Jiang Y, Jia MM, Yang GH. Increased lung cancer mortality rates in the chinese population from 1973-1975 to 2004-2005: an adverse health effect from exposure to smoking. Cancer. 2015;1:3107- 12. https://doi.org/10.1002/cncr.29603

  19. Boffetta P, La Vecchia C, Levi F, Lucchini F. Mortality patterns and trends for lung cancer and other tobacco-related cancers in the Americas, 1955-1989. Int J Epidemiol. 1993; 22(3):377-84. https://doi. org/10.1093/ije/22.3.377

  20. Borja-Aburto VH, Sousa-Santana V. Environmental and social determinants of health. Work and health in the Americas. Washington DC: PAHO, 2016. [citado mayo 15, 2018]. Disponible en: https://www.paho.org/blogs/ paltex/wp-content/uploads/2016/06/preliminares_english_finkelman.pdf

  21. Alberg AJ, Shopland DR, Cummings KM. The 2014 Surgeon General’s report: commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and updating the evidence on the health consequences of cigarette smoking. Am J Epidemiol. 2014;179(4):403-12. https://doi.org/10.1093/aje/kwt335

  22. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz (INPRFM). Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2016-2017: Reporte de Tabaco. CDMX: Secretaría de Salud, 2017. [citado mayo 15, 2018]. Disponible en: https://www.gob.mx/salud%7Cconadic/acciones-yprogramas/ encuesta-nacional-de-consumo-de-drogas-alcohol-y-tabacoencodat- 2016-2017-136758

  23. Arrieta O, Lopez-Mejia M, Macedo-Perez EO, Corona-Cruz JF. Proposals for the prevention of lung cancer in the health system of Mexico. Salud Publica Mex. 2016;58(2):274-8. https://doi.org/10.21149/spm.v58i2.7796

  24. Ruiz-Godoy L, Rizo-Rios P, Sanchez-Cervantes F, Osornio-Vargas A, Garcia-Cuellar C, Meneses Garcia A. Mortality due to lung cancer in Mexico. Lung Cancer. 2007;58(2):184-90. https://doi.org/10.1016/j. lungcan.2007.06.007

  25. Yuan P, Cao JL, Rustam A, Zhang C, Yuan XS, Bao FC, et al. Time-to- Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute. Sci Rep. 2016;6:28477. https:// doi.org/10.1038/srep28477

  26. Wao H, Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis. Syst Rev. 2013;2:10. https://doi. org/10.1186/2046-4053-2-10

  27. Knaul FM, Arreola-Ornelas H, Wong R, Lugo-Palacios DG, Mendez- Carniado O. The effect of Seguro Popular de Salud on catastrophic and impoverishing expenditures in Mexico, 2004-2012. Salud Publica Mex. 2018;60(2):130-40. https://doi.org/10.21149/9064

  28. Pichon-Riviere A, Bardach A, Augustovski F, Alcaraz A, Reynales-Shigematsu LM, Pinto MT, et al. Financial impact of smoking on health systems in Latin America: A study of seven countries and extrapolation to the regional level. Rev Panam Salud Publica. 2016;40(4):213-221.

  29. Valdes-Salgado R, Avila-Tang E, Stillman FA, Wipfli H, Samet JM. Leyes que prohiben fumar en espacios cerrados en México. Salud Publica Mex. 2008;50(supl 3):S334-42.




2020     |     www.medigraphic.com